Burdziak C, Alonso-Curbelo D, Walle T, Reyes J, Barriga FM, Haviv D, Xie Y, Zhao Z, Zhao CJulia, Chen H-A et al..  2023.  Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis.. Science. 380(6645):eadd5327.

Gartrell RD, Enzler T, Kim PS, Fullerton BT, Fazlollahi L, Chen AX, Minns HE, Perni S, Weisberg SP, Rizk EM et al..  2022.  Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.. Oncoimmunology. 11(1):2066767.

de Geus SWL, Eskander MF, Kasumova GG, Ng SChau, Kent TS, Mancias JD, Callery MP, Mahadevan A, Tseng JF.  2017.  Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.. Cancer. 123(21):4158-4167.

Perez K, Clancy TE, Mancias JD, Rosenthal MH, Wolpin BM.  2017.  When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.. J Clin Oncol. 35(5):485-489.

Azzopardi S, Pang S, Klimstra DS, Du Y-CNancy.  2016.  p53 and p16/p19 Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.. Neoplasia. 18(10):610-617.

David CJ, Huang Y-H, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J.  2016.  TGF-β Tumor Suppression through a Lethal EMT.. Cell. 164(5):1015-30.

Rodić N, Steranka JP, Makohon-Moore A, Moyer A, Shen P, Sharma R, Kohutek ZA, Huang CRan, Ahn D, Mita P et al..  2015.  Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma.. Nat Med. 21(9):1060-4.

Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong S-M, Zhao M, Rudek MA, Khan SR et al..  2012.  A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists.. Mol Cancer Ther. 11(1):165-73.